This is an area that warrants further exploration, given that in vivo, many PDPN+ cells will be exposed to CLEC-2 signals, whether they are tumor cells interacting with CLEC-2+ platelets or FRCs interacting with CLEC-2+ DCs. This evidence concerns the gene CLEC1B and neoplasm.